{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:24:55Z","timestamp":1789061095765,"version":"build-2803163510"},"reference-count":25,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with hematologic malignancies (HMs) often receive aggressive end-of-life care and less frequently use hospice. Comprehensive longitudinal reporting on place of death, a key quality indicator, is lacking. Deidentified death certificate data were obtained via the National Center for Health Statistics for all HM deaths from 1999 to 2015. Multivariate regression analysis (MVA) was used to test for disparities in place of death associated with sociodemographic variables. During the study period, there were 951 435 HM deaths. Hospital deaths decreased from 54.6% in 1999 to 38.2% in 2015, whereas home (25.9% to 32.7%) and hospice facility deaths (0% to 12.1%) increased (all P &amp;lt; .001). On MVA of all cancers, HM patients had the lowest odds of home or hospice facility death (odds ratio [OR], 0.55; 95% confidence interval, 0.54-0.55). Older age (40-64 years: OR, 1.34; \u226565 years: OR, 1.89), being married (OR, 1.62), and having myeloma (OR, 1.34) were associated with home or hospice facility death, whereas being black or African American (OR, 0.68), Asian (OR, 0.58), or Hispanic (OR, 0.84) or having chronic leukemia (OR, 0.83) had decreased odds of dying at home or hospice (all P &amp;lt; .001). In conclusion, despite hospital deaths decreasing over time, patients with HMs remained more likely to die in the hospital than at home.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018023051","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T16:49:25Z","timestamp":1549039765000},"page":"333-338","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Disparities in place of death for patients with hematological malignancies, 1999 to 2015"],"prefix":"10.1182","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-488X","authenticated-orcid":false,"given":"Fumiko","family":"Chino","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Duke University Medical Center, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif H.","family":"Kamal","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Duke Cancer Institute, Durham, NC;"},{"name":"Duke Palliative Care, Durham, NC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-9685","authenticated-orcid":false,"given":"Junzo","family":"Chino","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Duke University Medical Center, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-7895","authenticated-orcid":false,"given":"Thomas W.","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Cellular Therapy, Duke Cancer Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"2020021108332524600_B1","unstructured":"American Cancer Society. Cancer Facts & Figures, 2018. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2018\/cancer-facts-and-figures-2018.pdf. Accessed 18 March 2018."},{"key":"2020021108332524600_B2","unstructured":"Macmillan Cancer Support. No regrets: How talking more openly about death could help people die well. https:\/\/www.macmillan.org.uk\/documents\/aboutus\/health_professionals\/endoflife\/no-regrets-talking-about-death-report.pdf. Accessed 9 May 2018."},{"issue":"8","key":"2020021108332524600_B3","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/annonc\/mdr602","article-title":"Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain","volume":"23","author":"Gomes","year":"2012","journal-title":"Ann Oncol"},{"issue":"23","key":"2020021108332524600_B4","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020021108332524600_B5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0269216317735246","article-title":"Palliative care in patients with haematological neoplasms: An integrative systematic review","volume":"32","author":"Moreno-Alonso","year":"2018","journal-title":"Palliat Med"},{"issue":"8","key":"2020021108332524600_B6","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2002.08.138","article-title":"Place of death and its predictors for local patients registered at a comprehensive cancer center","volume":"20","author":"Bruera","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020021108332524600_B7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpainsymman.2014.07.003","article-title":"What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network","volume":"49","author":"LeBlanc","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"30","key":"2020021108332524600_B8","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1200\/JCO.2017.72.7149","article-title":"Health care use by older adults with acute myeloid leukemia at the end of life","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"issue":"16","key":"2020021108332524600_B9","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/cncr.29430","article-title":"Health care utilization and end-of-life care for older patients with acute myeloid leukemia","volume":"121","author":"El-Jawahri","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"2020021108332524600_B10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jama.291.1.88","article-title":"Family perspectives on end-of-life care at the last place of care","volume":"291","author":"Teno","year":"2004","journal-title":"JAMA"},{"issue":"29","key":"2020021108332524600_B11","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1200\/JCO.2009.26.3863","article-title":"Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers\u2019 mental health","volume":"28","author":"Wright","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"2020021108332524600_B12","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1200\/JCO.2009.25.4672","article-title":"End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences","volume":"28","author":"Mack","year":"2010","journal-title":"J Clin Oncol"},{"issue":"27","key":"2020021108332524600_B13","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2011.40.8872","article-title":"Randomized controlled trial of a structured intervention to facilitate end-of-life decision making in patients with advanced cancer","volume":"31","author":"Stein","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020021108332524600_B14","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1200\/JOP.2014.001859","article-title":"Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study","volume":"11","author":"LeBlanc","year":"2015","journal-title":"J Oncol Pract"},{"issue":"7","key":"2020021108332524600_B15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/annonc\/mdv028","article-title":"Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists","volume":"26","author":"Hui","year":"2015","journal-title":"Ann Oncol"},{"issue":"26","key":"2020021108332524600_B16","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2016.67.8177","article-title":"Barriers to quality end-of-life care for patients with blood cancers","volume":"34","author":"Odejide","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020021108332524600_B17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bmjspcare-2014-000793","article-title":"Preferred and actual place of death in haematological malignancy","volume":"7","author":"Howell","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"2020021108332524600_B18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpainsymman.2017.08.030","article-title":"Comparing the palliative care needs of patients with hematologic and solid malignancies","volume":"55","author":"Hochman","year":"2018","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2020021108332524600_B19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2018-03-842575","article-title":"Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia","volume":"132","author":"LeBlanc","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020021108332524600_B20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1472-684X-12-42","article-title":"Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death","volume":"12","author":"Howell","year":"2013","journal-title":"BMC Palliat Care"},{"issue":"11","key":"2020021108332524600_B21","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1089\/jpm.2010.0209","article-title":"Geographic access to hospice in the United States","volume":"13","author":"Carlson","year":"2010","journal-title":"J Palliat Med"},{"issue":"11","key":"2020021108332524600_B22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/bloodadvances.2018019125","article-title":"Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States","volume":"2","author":"Bhatt","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"2020021108332524600_B23","doi-asserted-by":"crossref","first-page":"djv280","DOI":"10.1093\/jnci\/djv280","article-title":"Hospice use among patients with lymphoma: impact of disease aggressiveness and curability","volume":"108","author":"Odejide","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2020021108332524600_B24","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3324\/haematol.2018.187609","article-title":"Meaningful changes in end-of-life care among patients with myeloma","volume":"103","author":"Odejide","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2020021108332524600_B25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/bjc.2016.162","article-title":"Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee","volume":"115","author":"Turner","year":"2016","journal-title":"Br J Cancer"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/3\/333\/1630834\/advances023051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/3\/333\/1630834\/advances023051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:01:50Z","timestamp":1581411710000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/3\/333\/246734\/Disparities-in-place-of-death-for-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018023051","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}